Lumilis, Luisa L.
HRN: 24-79-43 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/09/2024
04/09/2024
IV
500mg
Now
Thickly MSAF, For CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes